DAVITA INC. is 6.3x more valuable than Progyny, Inc. by market capitalization ($12.75 B vs $2.02 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DVA | PGNY |
|---|---|---|
| Market cap | $12.75 B | $2.02 B |
| US-listed rank | #812 | #2093 |
| Revenue (latest FY) | $13.64B | $1.29B |
| Net income (latest FY) | $1.08B | $58.52M |
| Net margin | 7.9% | 4.5% |
| P/E (trailing FY) | 11.8 | 34.5 |
| SEC filings | 3,248 | 893 |
DAVITA INC. is 6.3x more valuable than Progyny, Inc. by market capitalization ($12.75 B vs $2.02 B).
In their latest fiscal years, DAVITA INC. reported $13.64B in revenue while Progyny, Inc. reported $1.29B.
Full pages: DAVITA INC. and Progyny, Inc., or browse the full rankings.